+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade



Differential alpha-mediated inhibition of dopamine and noradrenaline release in the parietal and occipital cortex following noradrenaline transporter blockade



Journal of Neurochemistry 98(1): 113-121



Parietal and occipital cortices, while densely innervated by noradrenalin 2 (NA) projections, possess a comparatively sparse dopamine 2 (DA) innervation, even sparser than the prefrontal cortex. We previously reported that reboxetine and desipramine, two selective norepinephrine transporter (NET) blockers, at doses that maximally increase DA in the prefrontal cortex, do not increase DA in the parietal and occipital cortices. In the present study, we performed a full dose-response study of the effect of systemic reboxetine and desipramine on DA and NA in dialysates from the parietal and occipital cortices. Seven doses of reboxetine (0.1, 0.25, 0.5, 1.0, 2.5, 5.0 and 10 mg/kg) and four doses of desipramine (0.25, 1.0, 2.5 and 5.0 mg/kg) were tested. Reboxetine and desipramine differentially affected dialysate DA as compared with NA. Reboxetine increased DA maximally by about 100% after doses of 0.25-0.5 mg/kg and showed a bell-shaped dose-response function in both areas; desipramine did not affect DA in the parietal cortex and increased it in the occipital cortex only at 2.5 mg/kg. NA was maximally increased by 275% by 0.5-2.5 mg/kg reboxetine and by about 300% by 5.0 mg/kg desipramine with a more linear dose-response curve. The mechanism of peculiar dose-response function of dialysate DA after reboxetine and desipramine was further investigated by testing the effect of drugs on dialysate DA and NA under alpha(2) receptor blockade. Under local perfusion of the occipital cortex with idazoxan, an otherwise ineffective dose of reboxetine and desipramine (5 mg/kg) became effective in raising extracellular DA. In contrast, the effect of reboxetine on NA was potentiated, while that of desipramine was not affected. These results suggest that, in the parietal and occipital cortices, extracellular NA, raised by NET blockade, exerts a preferential inhibitory influence on DA release by acting on local alpha(2) receptors, thus accounting for the bell-shaped feature of the dose-response function of drugs on dialysate DA in these areas.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048787944

Download citation: RISBibTeXText

PMID: 16805801

DOI: 10.1111/j.1471-4159.2006.03851.x


Related references

Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of alpha methyl noradrenaline on the stimulation evoked release of tritium labeled noradrenaline from rat occipital cortex slices. European Journal of Pharmacology 64(2-3): 143-156, 1980

Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. Journal of Neurochemistry 88(4): 917-927, 2004

alpha-Adrenoceptor-mediated inhibition of noradrenaline release in rabbit brain cortex slices. Receptor properties and role of the biophase concentration of noradrenaline. Naunyn-Schmiedeberg's Archives of Pharmacology 319(1): 71-77, 1982

Influence of extracellular noradrenaline on the stimulation evoked secretion of noradrenaline from sympathetic nerves evidence for an alpha receptor mediated feedback inhibition of noradrenaline release. Naunyn Schmiedeberg's Archives of Pharmacology 275(1): 11-23, 1972

Effects of alpha-adrenoceptor antagonists on the release of serotonin and noradrenaline from rat brain cortex slices. Influence of noradrenaline uptake inhibition and determination of pA2 values. Naunyn-Schmiedeberg's Archives of Pharmacology 323(2): 106-113, 1983

Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of alpha-methylnoradrenaline on the stimulation-evoked release of 3H-noradrenaline from rat occipital cortex slices. European Journal of Pharmacology 64(2-3): 143-155, 1980

Influence of extracellular noradrenaline on the stimulation-evoked secretion of noradrenaline from sympathetic nerves: evidence for an -receptor-mediated feed-back inhibition of noradrenaline release. Naunyn-Schmiedeberg's Archives of Pharmacology 275(1): 11-23, 1972

Differential blockade by (-)mianserin of the alpha 2-adrenoceptors mediating inhibition of noradrenaline and serotonin release from rat brain synaptosomes. Naunyn-Schmiedeberg's Archives of Pharmacology 322(2): 180-182, 1983

Pertussis toxin differentiates between alpha 1- and alpha 2-adrenoceptor-mediated inhibition of noradrenaline release from rat kidney cortex. European Journal of Pharmacology 179(3): 435-439, 1990

The adenosine receptor mediated inhibition of noradrenaline release possibly involves a n protein and is increased by alpha 2 autoreceptor blockade. British Journal of Pharmacology 90(2): 403-412, 1987

Alpha 1 adrenoceptor inhibition of noradrenaline release from the rat kidney cortex is mediated by a 5 lipoxygenase metabolite of arachidonic acid. Journal of Neurochemistry 57(SUPPL): S134, 1991

Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. Journal of Neurochemistry 92(2): 368-374, 2005

Comparison of the alpha 2 adrenoceptors which modulate noradrenaline release in rabbits and rat occipital cortex. British Journal of Pharmacology 85(SUPPL): 318P, 1985

On the role of calcium ions in the presynaptic alpha-receptor mediated inhibition of [3H]noradrenaline release from rat brain cortex synaptosomes. Brain Research 185(2): 399-408, 1980

The effect of cyclic amp on the inhibition of noradrenaline release from rat occipital cortex tissue chops by clonidine. Biochemical Society Transactions 16(3): 311-312, 1988